Tag: Vertex Pharmaceuticals

September 3, 2019 Off

Vertex buys Semma Therapeutics for $950M

By Dino Mustafić

Vertex Pharmaceuticals Incorporated will acquire Semma Therapeutics, a privately held biotechnology company pioneering the use of stem cell-derived human islets as a potentially curative treatment for type 1 diabetes, for $950 million in cash.